title: Medical management of paediatric burn injuries: best practice part 2.
abstract: Burns remain a leading cause of injury in the paediatric population in Australia despite efforts in prevention. Advances in surgical management include novel debridement methods and blood conserving techniques. Patients with severe burns (>20%) remain significantly more complex to manage as a result of extensive alterations in metabolic processes. There appears increasing evidence to support the use of pharmacological modulators of the hyper-metabolic state in these patients. The management of a child with burns involves acute, subacute and long-term planning. This holistic approach seems optimally co-ordinated by a Burns Unit in which each discipline required to provide care to these children in order to achieve optimal outcomes is represented.
authors.affiliation: Burns Unit, The Children's Hospital at Westmead Burns Research Institute, Sydney, New South Wales, Australia; Douglas Cohen Department of Paediatric Surgery, The Children's Hospital at Westmead, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
authors.forename: Rachel
authors.initials: R
authors.lastname: D'Cruz
authors.forename: Hugh C O
authors.initials: HC
authors.lastname: Martin
authors.forename: Andrew J A
authors.initials: AJ
authors.lastname: Holland
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control; D057668:Bloodless Medical and Surgical Procedures / Q000379:methods; D002053:Burn Units; D002056:Burns / Q000150:complications / Q000628:therapy*; D002648:Child; D003131:Combined Modality Therapy; D003422:Critical Care / Q000379:methods*; D003646:Debridement / Q000379:methods; D004837:Epinephrine / Q000627:therapeutic use; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D008659:Metabolic Diseases / Q000188:drug therapy / Q000209:etiology; D018529:Nutritional Support / Q000379:methods; D010348:Patient Care Team; D013917:Thrombin / Q000627:therapeutic use; D014111:Tourniquets; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D045930:Anabolic Agents; D006490:Hemostatics; D014662:Vasoconstrictor Agents; D013917:Thrombin; D004837:Epinephrine
keywords: blood; burn; debridement; metabolism; multidisciplinary team; nutrition